HALO logo
VRTX
Vertex Pharmaceuticals Incorporated

VRTX · Vertex Pharmaceuticals Incorporated

499.74

USD
-9.01 (-1.771%)
16/10/2026 04:00:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$129.29B

PE

N/A

EV/EBITDA

N/A

DIV Yield

N/A

Payout Ratio

N/A

MQV Rating

4Weak

As at 16/10/2026 04:00:00 PM

Price Chart

Description

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • Engulfing Bearish (Realtime)
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Balance Sheet
  • Hammer Bearish

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

N/A

Trade Value (12mth)

N/A

1 week

%

1 month

%

YTD

%

1 year

%

All time high

N/A

Additional Data

Shares Outstanding (Fully Diluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

N/A

Short Sell (% of issue)

lock

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
02 September 26EDG
05 August 26EDG
05 August 26EDG
04 August 26EDG
04 August 26EDG

Key Stakeholders

NameTitle
Amit K. SachdevIndividual
Stuart A. ArbuckleIndividual
Ourania TatsisIndividual
Reshma KewalramaniIndividual
Ourania TatsisIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The current share price of Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$499.74.
2
What is the 52-week high share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The 52-week high share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$0.00.
3
What is the 52-week low share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The 52-week low share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$0.00.
4
What is the dividend yield for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) does not pay a dividend.
5
What was Vertex Pharmaceuticals Incorporated (VRTX:NAS) last dividend payment?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) does not pay a dividend.
6
What is the franking level for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) has a franking level of 0.00%.
7
In which sector is Vertex Pharmaceuticals Incorporated (VRTX:NAS) classified?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) is classified in the Healthcare.